BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HemoCue Decides To Enforce Decision In Patent Infringement Suit Against EKF diagnostic GmbH


4/5/2006 10:50:56 AM

ANGELHOLM, Sweden, April 5 /PRNewswire/ -- March 9th this year, HemoCue won an important victory in a lawsuit against EKF-diagnostics GmbH in the District Court of Dusseldorf, Germany. Yesterday EKF was informed of HemoCue's decision to enforce the District Court's decision. This means that EKF no longer can manufacture, or sell, the infringing product.

Says HemoCue's Director of Corporate Affairs, Clas Runnberg; "In our opinion, the decision, and the reasoning upon which it is based, is entirely in HemoCue's favor. This made it very easy for us to determine that we wanted the first instance decision enforced immediately. We have also decided to exercise our right to request that EKF communicates information about sales of product covered by our patent."

The decision is related to a patent involved in multiple processes, both in Germany and in the United States. Most likely, these will continue for years to come, but the company stills regards the victory as decisive. The Court in Dusseldorf is one of Europe's most respected in patent litigation. Subject to appeal, the enforcement of the decision means that it is no longer permissible for EKF to manufacture the infringing product, nor is the company allowed to sell it in or out from Germany, irrespective of intended destination.

For additional product information, please visit .

HemoCue is a leading global company in a field of diagnostic testing known as point-of-care testing. In 1982, the company introduced the first system making accurate hemoglobin testing possible outside the hospital environment. The system consists of an instrument and a disposable microcuvette used with each test. Since then, HemoCue has installed more than 200,000 systems world wide which are being used to deliver about 100 million tests each year.

HemoCue AB

CONTACT: Clas Runnberg, Director of Corporate Affairs, HemoCue AB, +46 43145 82 70, clas.runnberg@hemocue.se



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES